Now, a new study recently published in the journal Nature Medicine reports that taking GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered dementia and addiction risks
Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control
^ Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
Supplementation with antioxidants appears to reduce lipid peroxidation but has not been shown to enhance exercise performance
At our Manhattan practice, were seeing increasing numbers of patients using GLP-1 medications, often without realizing the potential impact these medications can have on mood, anxiety, and overall psychological wellbeing
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure